99mTc-fanolesomab Palatin Technologies

IDrugs

Volumn 6, Issue 11, 2003, Pages 1079-1085

  Love, Charito ^a   Palestro, Christopher J ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANOLESOMAB TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEUKOCYTE IN 111; NCA 95 ANTIBODY BW 250 183 TC 99M; RADIOPHARMACEUTICAL AGENT; SULESOMAB TC 99M; UNCLASSIFIED DRUG; CD15 ANTIGEN; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ANTI SSEA 1; MONOCLONAL ANTIBODY ANTI-SSEA-1; TECHNETIUM;

ANTIBODY PRODUCTION; APPENDICITIS; BINDING KINETICS; BLOOD CELL; BLOOD PRESSURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG SYNTHESIS; DRUG WITHDRAWAL; DYSPNEA; ENTERITIS; FLUSHING; HEADACHE; HUMAN; HYPERTHERMIA; INFECTION; ISOTOPE LABELING; LEUKOPENIA; LUNG DISEASE; NEUTROPHIL; NONHUMAN; OSTEOMYELITIS; PAIN; PARESTHESIA; PHARYNGITIS; PULSE RATE; RADIOACTIVITY; RADIODIAGNOSIS; RECEPTOR AFFINITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; SYMPTOMATOLOGY; SYNCOPE; VASODILATATION; VERTIGO; ANIMAL; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; CLINICAL TRIALS; HUMANS; INFECTION; INJECTIONS, INTRAVENOUS; RADIOPHARMACEUTICALS; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNETIUM;

EID: 0344099030     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. 195097 The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Becker W, Goldenberg DM, Wolf F Semin Nucl Med 1994 24 2 142-153
2. 302827 Company brochure - Palatin Technologies. Palatin Technologies Inc Company Prospectus 1998 October
3. 304195 Open house presentation - Palatin Technologies Inc. Ann Biopartnering Europe Meet 1998 October 26-27
4. 313594 Palatin starts phase 2 LeuTech study for osteomyelitis. Palatin Technologies Inc Press Release 1999 February 04
5. 314439 Palatin Technologies completes $3.8 million private placement. Palatin Technologies Inc Press Release 1999 February 09
6. 318598 Palatin completes enrollment of phase III LeuTech clinical trials at ten major US sites. Palatin Technologies Inc Press Release 1999 March 17
7. 322706 Palatin Technologies announces phase 3 data for LeuTech infection imaging agent. Palatin Technologies Inc Press Release 1999 April 26
8. 99mTC-labelled anti-WBC antibody (LeuTech) for diagnosing acute apendicitis with equivocal presentation. Rypins EB, Kipper SL Gastroenterology 1999 114 4 Pt 2 Abs 2180
9. 336916 Mallinckrodt, Palatin sign binding agreement to market LeuTech, Palatin's infection imaging agent - Palatin receives $13.5 million in initial payments. Mallinckrodt Inc Press Release 1999 August 17
10. 348390 Palatin submits Biologics License Application to FDA seeking clearance to market LeuTech infection imaging agent. Palatin Technologies Inc Press Release 1999 November 23
11. 354252 FDA accepts Palatin Technologies' LeuTech Biologics License Application for full review - Clinical trials continuing for other indications. Palatin Technologies Inc Press Release 2000 February 02
12. 369709 LeuTech reaches two major development milestones. Palatin Technologies Inc Press Release 2000 June 05
13. 370190 Clinical trial results of Palatin Technologies' LeuTech show promise for new infection imaging agent. Palatin Technology Inc Press Release 2000 June 07
14. 373280 FDA Advisory Committee meetings. FDC Reports Pink Sheet 2000 62 27 30
15. 373921 FDA Advisory Committee finds Palatin Technologies' LeuTech infection imaging agent safe and effective in unanimous votes. Palatin Technologies Inc Press Release 2000 July 10
16. 376524 Palatin LeuTech diagnostic cost-effectiveness analysis under way. FDC Reports Pink Sheet 2000 62 30 32-33
17. 99mTc-labeled anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis. Kipper SL, Rypins EB, Evans DG, Thakur ML, Smith TD, Rhodes B J Nucl Med 2000 41 3 449-455
18. 413507 Palatin Technologies presents LeuTech phase II results for imaging osteomyelitis at the Society of Nuclear Medicine Annual Meeting. Palatin Technologies Inc Press Release 2001 June 25
19. 451197 Palatin and Tyco/Healthcare/Mallinckrodt amend LeuTech marketing agreement. Palatin Technologies Inc, Tyco/Healthcare/Mallinckrodt Press Release 2002 May 15
20. 99mTc anti-CD15 monoclonal antibody (LeuTech) imaging improves diagnostic accuracy and clinical management in patients with equivocal presentation of appendicitis. Rypins EB, Kipper SL, Weiland F, Neal C, Line B, McDonald R, Klonecke A, Barron B, Palestro CJ, Waxman A, Bunker S et al. Ann Surg 2002 235 2 232-239
21. 99mTc-fanolesomab.
22. 487070 Palatin Technologies Inc reports positive LeuTech data in diabetic patients with suspected pedal osteomyelitis. Palatin Technologies Inc Press Release 2003 April 24
23. 484530 Products: Product Pipeline. Palatin Technologies Inc Company World Wide Web Site 2003 April 01
24. 500212 Monoclonal antibodies as agents for selective radiolabeling of human neutrophils. Thakur ML, Richard MD, White FW III J Nucl Med 1988 29 11 1817-1825 This article provides a comprehensive review of the science of in vivo selective leukocyte labeling with use of monoclonal antibodies.
25. 99m-labeled monoclonal antibody anti-SSEA-1. Thakur ML, Marcus CS, Henneman P, Butler J, Sinow R, Diggles L, Minami C, Mason G, Klein S, Rhodes B J Nucl Med 1996 37 11 1789-1795 This article formed the basis for subsequent clinical trials.
26. 99mTc-HMPAO labeled white blood cells for the imaging of infection. Gratz S, Behr T, Herrmann A, Dresing K, Tarditi L, Franceschini R, Rhodes B, Stürmer KM, Becker W Eur J Nucl Med 1998 25 4 386-393
27. 500216 Human neutrophils: Evaluation of adherence, chemotaxis, and phagocytosis, following interaction with radiolabeled antibodies. Thakur ML, Lee J, DeFulvio MD, Richard MD, Park CH Nucl Med Commun 1990 11 1 37-43
28. 99mTc-fanolesomab.
29. 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. Mozley PD, Stubbs JB, Dresel SH, Barraclough ED, Smith T, Patel M, Finkelman C, Sparks RB, Thakur ML, Mathur A, Alavi A J Nucl Med 1999 40 4 625-630
30. 111In-labeled leukocytes - Initial experience. Palestro CJ, Kipper SL, Weiland FL, Love C, Tomas MB Radiology 2002 223 3 758-764
31. 500277 Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody. Palestro CJ, Caprioli R, Love C, Richardson HL, Kipper SL, Weiland FL, Tomas MB J Ft Ank Surg 2003 42 1 2-8
32. 99mTc-fanolesomab. Palatin Technologies Inc Company Communication 2003 August 19
33. 506950 Palatin Technologies Inc reports fourth quarter, year end 2003 results teleconference and webcast to be held October 1, 2003. Palatin Technologies Inc Press Release 2003 September 30
34. 506973 The role of nuclear medicine in infection and inflammation. Becker W, Meller J Lancet Infect Dis 2001 1 5 326-333
35. 99m LeuTech). Palatin Technologies Inc Company Brochure 2001 January 8 1-74
36. 507005 The single late Tc-99m-granulocyte antibody scan in inflammatory diseases. Becker W, Saptogino A, Wolf FG Nucl Med Commun 1992 13 3 186-192
37. 507007 Leukoscan for imaging infection in different clinical settings: A retrospective evaluation and extended review of the literature. Gratz S, Schipper ML, Dorner J, Hoffken H, Becker W, Kaiser JW, Behe M, Behr TM Clin Nucl Med 2003 28 4 267-276
38. 507021 Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan). Becker W, Palestro CJ, Winship J, Feld T, Pinsky CM, Wolf F, Goldenberg DM Clin Orthop 1996 329 263-272
39. 507029 Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Hakki S, Harwood SJ, Morrissey MA, Camblin JG, Laven DL, Webster WB Jr. Clin Orthop 1997 335 275-285
40. 507030 Comparison of Tc-99m-labelled antileukocyte fragment Fab′ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: A prospective study. Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C, Girault S, Moisan A, Bourguet P Nucl Med Comm 2000 21 8 747-753
41. 507031 Efficacy and safety of sulesomab (Leukoscan) in the diagnosis of acute non-classic appendicitis. Baron B, Lamki L, Hanna C, Passalaqua A, Wegener G, Pinsky CM, Hammershaimb L, Marks DH, Goldenberg DM J Nucl Med 1997 38 Suppl 25P